Table 1: Clinical and biochemical characteristics of heart failure patients.

Patients
NYHA I-II
( )
Patients
NYHA III-IV
( )

Age, yrs 0.801
Male, (%)9 (100)7 (50)0.019
BMI, kg/m2 0.557
Diabetes, (%)1 (11)3 (21)1.000
Etiology, (%)0.611
 IDC8 (89)10 (71)
 IHD1 (11)4 (29)
LVEDV, mL 0.027
LVESV, mL 0.055
LVEF, % 0.159
MID, (%)0.074
 01 (11)
 1+5 (56)2 (14)
 2+2 (22)8 (57)
 3+1 (11)4 (29)
 4+
LA area, cm2 0.007
Therapy, (%)
 ACEi7 (79)8 (57)0.400
β-Blocker9 (100)14 (100)1.000
 Statin4 (44)7 (50)1.000
 Antiplatelets6 (67)8 (57)1.000
 Diuretic7 (78)14 (100)0.142
C-reactive protein, mg/dL 0.410

Data are expressed as mean and SE or frequency (percentage).
BMI: body mass index; IDC: idiopathic dilated cardiomyopathy; IHD: ischemic heart disease; NYHA: New York Heart Classification; LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume; MID: mitral insufficiency grade; LA: left atrium; ACEi: angiotensin converting enzyme inhibitor.